Free Newsletters | Help  

  Current | By Company | NEW Products
Login ID:    Password:    Register for a FREE account
 NEWS

Industry News
Business
Organic
Food & Beverage
Sports Nutrition
Nutraceuticals
Regulatory
Research
Products
Practitioners
Retail
Events
People
On-line


 LISTINGS
  Categories
Products

Profiles
Publishers

 OPINION
  Editorials
Interviews
Up and Comers
Quality Initiatives

 
Blogs
Andrew Stewart  
Marc Ullman FYI Blog
Len Monheit Off The Cuff
James S. Tonkin - Formulating Beverages  
Jim Lassiter -- Good News/Bad News
The Nutrition Business Journal Blog

Join the NPIcenter LinkedIn Group Group
Join the Facebook page Page
Follow us on
Join the Facebook page


 FEATURES
 

Newsletter

  News Feeds
 
 SERVICES
  Log in
Register User
Add Company
Career Center
Advertise

 INFO CENTER
  Help
Contact Us
About NPI
Privacy Policy



 

Advertisement



Share Subscribe to NPIcenter Newsfeed

Kyowa Hakko USA Announces GRAS Self-Affirmation for Brain Health Ingredient Cognizin® Citicoline
2009-06-01 - Kyowa Hakko USA, Inc.




Kyowa Hakko U.S.A., Inc.(Kyowa Hakko USA), the wholly-owned subsidiary of Kyowa Hakko Bio Co., Ltd., (Kyowa), has announced it has completed GRAS (Generally Recognized As Safe) self-affirmation for the novel brain health ingredient Cognizin® Citicoline.
           
Cognizin® is a branded form of Citicoline, a natural nutrient found in every cell of the body. Citicoline provides an essential nutrient for cells — particularly brain cells. Cognizin® supports brain health in several ways.
           
First, brain imaging technology has shown that Cognizin® helps increase brain energy.* Second, Cognizin® provides essential structural components for synthesizing brain cell membranes, which may help facilitate brain cell communication.* Lastly, Cognizin® helps support the formation of several brain nutrients that regulate cognitive function.* Cognizin® has been the subject of several human clinical trials.
           
The most recent trial studied the effect of Cognizin® on healthy middle-aged adults. Using the latest brain scanning technology, researchers at the Harvard-associated Brain Imaging Center at McLean Hospital in Boston, observed increases in brain activity among people who had taken Cognizin® for six weeks, particularly when individuals performed tasks that required sustained attention or memory.
           
Because Cognizin® helps make more energy available to brain cells, they are better able to perform their daily tasks. Cell membranes are synthesized and maintained. Vital brain nutrients are produced and electrical impulses are generated.

These activities may help improve the overall functioning of the brain, which is why Cognizin® may significantly increase the ability to focus, concentrate, and make decisions.*
           
Cognizin® Citicoline or CDP-choline will be marketed by Kyowa Hakko USA as a food ingredient in the United States for use at levels of 250 mg/serving in various food products, beverages and beverage bases, breakfast cereals, chewing gum, dairy product analogs, frozen dairy desserts, grain products and pastas, hard candies, milk and milk products, processed fruits and fruit juices, and soft candy.

In addition to Cognizin® brand Citicoline, Kyowa is the maker of other leading branded ingredients including Hydrafend™ Hyaluronic Acid, Lumistor® L-Hydroxyproline, Kyowa CoQ10®, Setria® Glutathione and Sustamine™ Alanyl Glutamine. Kyowa offers manufacturers and formulators one of the industry’s most extensive lines of over 50 amino acids and related compounds, including D-Amino acids and branch-chain amino acids, as well as nucleic acids, bio-products and fine chemicals.

For more information about Cognizin® brand Citicoline, contact Kyowa Hakko USA at 212.319.5353 or visit the web site at www.Cognizin.com.

*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.

Related Articles :

  • Makoto Yagasaki, Ph.D., of Kyowa Hakko to Speak About New Fermentation Technology Breakthroughs at Nutracon (2009-02-25)
    Makoto Yagasaki, Ph.D., principal scientist for Kyowa Hakko Bio, will be one of the featured speakers discussing New Fermentology Breakthroughs on Wednesday, March 4 at Nutracon.
  • Kyowa Hakko USA Launches Setria® Glutathione Web Site (2009-03-24)
    Kyowa Hakko has announced it has launched www.SetriaGlutathione.com, a new web site for its branded ingredient.
  • Kyowa Hakko Kirin Fiscal 2008 Sales up 17.4%, Operating Income up 15.2% (2009-04-28)
    Kyowa Hakko Kirin Co., Ltd., has announced its consolidated financial results for the year ended March 31, 2009 (Fiscal 2008). Consolidated net sales were JPY460.1 billion, up 17.4% and consolidated operating income was JPY45.3 billion, an increase of 15.2% compared to fiscal 2007. Recurring income increased 22.2% to JPY46.4 billion. Net income decreased by 50% to JPY11.7 billion, as extraordinary losses of JPY21.5 billion were recorded due to valuation losses on investment securities, impairment losses and other factors.
  •  

    Advertisement



    Sponsored Links: Featured Links:
     

    NPIcenter Address and Phone Number
    Contact Us | Privacy Policy | Terms of Use | Advertise
    New Hope Natural Media

     

    SUPPLYEXPO Funtional Foods & Nutraceuticals Magazine Healthy Foods Conferences The Newport Summit - Executive Retreat Nutracon